Lyra Therapeutics Inc Stock Performance
as on September 16, 2025 at 1:17 am IST
Day's Low
Day's High
$6.19$6.34
1.12%
Downside
1.28%
Upside
52 Week's Low
52 Week's High
$3.81$37.539.14%
Downside
499.04%
Upside
Lyra Therapeutics Inc share price movements today
- Previous Close
- $6.29
- Open
- $6.28
- Volume
- 102.7K
- Day's Low - High
- $6.19 - $6.34
- 52 Week Low - High
- $3.81 - $37.5
Lyra Therapeutics Inc Historical Returns
- 1 Month Return
- -10.78 %
- 3 Month Return
- -44.53 %
- 1 Year Return
- -55.07 %
- 3 Year Return
- -97.89 %
- 5 Year Return
- -98.91 %
Lyra Therapeutics Inc Stock Fundamentals & Key Indicators
Check Lyra Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.3M
EPS (TTM)
-21
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.2
Industry PE ratio
0P/B Ratio
0PEG Ratio
0EBITDA
-35.3M
Revenue (TTM)
770.0K
Profit Margin
0.00%
Return On Equity TTM
60022000.00%
Lyra Therapeutics Inc Stock Valuation
Track how Lyra Therapeutics Inc P/E has moved over time to understand its valuation trends.
Lyra Therapeutics Inc in the last 5 years
Lowest (0.00x)
September 15, 2025
Industry (0.00x)
September 15, 2025
Today (-0.20x)
September 15, 2025
Highest (0.00x)
September 15, 2025
Today’s Price to Earnings Ratio: -0.20x
Lyra Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Lyra Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $10.3M | -98.91% | -0.2 | 0.00% | |
| BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
| NA | $38.7B | NA | NA | -3.89% | |
| BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
| BUY | $59.4B | -3.43% | 14.11 | 31.37% |
Stock Returns calculator for Lyra Therapeutics Inc Stock including INR - Dollar returns
The Lyra Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Lyra Therapeutics Inc investment value today
Current value as on today
₹49,700
Returns
Returns from Lyra Therapeutics Inc Stock
Dollar Returns*
₹4,985 (+4.99%)
Analyst Recommendation on Lyra Therapeutics Inc Stock
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Lyra Therapeutics Inc. Average target price of $11.5
Lyra Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Lyra Therapeutics Inc.
What analysts predicted
45.57%UPSIDE
Target Price
$11.5
Current Price
$6.26
Analyzed by
12 Analysts
Target
$11.50
Lyra Therapeutics Inc target price $11.5, a slight upside of 45.57% compared to current price of $6.26. According to 12 analysts rating.
Lyra Therapeutics Inc Stock's Interest Amongst Investors
Search interest for Lyra Therapeutics Inc Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Lyra Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Lyra Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Lyra Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Lyra Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Lyra Therapeutics Inc
Insights on Lyra Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 5 quarters, -48.13M → -7.43M (in $), with an average increase of 89.2% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 221.4%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 130.7%
NEGATIVE IMPACTPrice Dip
In the last 1 month, LYRA stock has moved down by -10.8%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 209.0K → 183.0K (in $), with an average decrease of 6.2% per quarter
About Lyra Therapeutics Inc
| Organisation | Lyra Therapeutics Inc |
| Headquarters | 480 Arsenal Way, Watertown, MA, United States, 02472 |
| Industry | Health Technology |
| CEO | Dr. Maria Palasis Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Lyra Therapeutics Inc
Name | Title |
|---|---|
Ms. Allison Nance | Senior Vice President of Regulatory Affairs |
Mr. Ronan P. O'Brien J.D. | Chief Legal Officer |
Ms. Vineeta Belanger Ph.D. | Senior Vice President of Clinical Affairs |
Dr. Robert Kern M.D. | Chief Clinical Advisor |
Ms. Gloria Cosgrove | Senior Vice President of Quality |
Dr. Maria Palasis Ph.D. | CEO, President & Chairman |
Mr. Jason Cavalier | CFO, Treasurer & Secretary |
Dr. Carmichael S. Roberts Jr., Ph.D. | Co-Founder |
Dr. Elazer R. Edelman FACC, M.D., Ph.D. | VP of Finance & Risk |
FAQs
What is Lyra Therapeutics Inc share price today?
Lyra Therapeutics Inc share price today is $6.26 as on at the close of the market. Lyra Therapeutics Inc share today touched a day high of $6.34 and a low of $6.19.
What is the 52 week high and 52 week low for Lyra Therapeutics Inc share?
Lyra Therapeutics Inc share touched a 52 week high of $37.5 on and a 52 week low of $3.81 on . Lyra Therapeutics Inc stock price today i.e. is closed at $6.26,which is 83.31% down from its 52 week high and 64.30% up from its 52 week low.
What is Lyra Therapeutics Inc's market capitalisation today?
Lyra Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Lyra Therapeutics Inc Stock (LYRA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Lyra Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lyra Therapeutics Inc Shares that will get you 0.2396 shares as per Lyra Therapeutics Inc share price of $6.26 per share as on September 16, 2025 at 1:17 am IST.
What is the minimum amount required to buy Lyra Therapeutics Inc Stock (LYRA) from India?
Indian investors can start investing in Lyra Therapeutics Inc (LYRA) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Lyra Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Lyra Therapeutics Inc share’s latest price of $6.26 as on September 16, 2025 at 1:17 am IST, you will get 1.5974 shares of Lyra Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Lyra Therapeutics Inc has given to Indian investors in the last 5 years?
Lyra Therapeutics Inc stock has given -98.91% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?